Mouse embryo geometry drives formation of robust signaling gradients through receptor localization.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
04 10 2019
Historique:
received: 06 12 2018
accepted: 12 09 2019
entrez: 6 10 2019
pubmed: 6 10 2019
medline: 15 2 2020
Statut: epublish

Résumé

Morphogen signals are essential for cell fate specification during embryogenesis. Some receptors that sense these morphogens are known to localize to only the apical or basolateral membrane of polarized cell lines in vitro. How such localization affects morphogen sensing and patterning in the developing embryo remains unknown. Here, we show that the formation of a robust BMP signaling gradient in the early mouse embryo depends on the restricted, basolateral localization of BMP receptors. The mis-localization of receptors to the apical membrane results in ectopic BMP signaling in the mouse epiblast in vivo. With evidence from mathematical modeling, human embryonic stem cells in vitro, and mouse embryos in vivo, we find that the geometric compartmentalization of BMP receptors and ligands creates a signaling gradient that is buffered against fluctuations. Our results demonstrate the importance of receptor localization and embryo geometry in shaping morphogen signaling during embryogenesis.

Identifiants

pubmed: 31586065
doi: 10.1038/s41467-019-12533-7
pii: 10.1038/s41467-019-12533-7
pmc: PMC6778081
doi:

Substances chimiques

Bmp4 protein, mouse 0
Bone Morphogenetic Protein 4 0
Ligands 0
Bone Morphogenetic Protein Receptors EC 2.7.11.30

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

4516

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM131105
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM107000
Pays : United States

Références

Genes Dev. 1995 Dec 15;9(24):3027-37
pubmed: 8543149
Science. 2017 Apr 14;356(6334):
pubmed: 28254784
Nat Rev Mol Cell Biol. 2008 Nov;9(11):887-901
pubmed: 18946477
Cell. 2000 Dec 8;103(6):971-80
pubmed: 11136981
Science. 2007 Jan 26;315(5811):521-5
pubmed: 17255514
Dev Biol. 2000 May 1;221(1):249-58
pubmed: 10772805
Cell. 2014 Feb 27;156(5):1032-44
pubmed: 24529478
Cell. 2019 Jun 27;178(1):12-25
pubmed: 31251912
Nat Biotechnol. 2011 Aug 05;29(8):697-8
pubmed: 21822241
Int J Dev Biol. 2013;57(1):61-7
pubmed: 23585354
Cell. 2000 Dec 8;103(6):981-91
pubmed: 11136982
Nature. 2003 Mar 20;422(6929):322-6
pubmed: 12646923
Nature. 2008 Jun 26;453(7199):1205-11
pubmed: 18580943
Mol Biol Cell. 2004 Jun;15(6):2853-62
pubmed: 15075369
Cell. 1987 Oct 9;51(1):151-8
pubmed: 3115594
Nat Rev Mol Cell Biol. 2009 Feb;10(2):91-103
pubmed: 19129791
Dev Cell. 2019 Mar 25;48(6):751-763
pubmed: 30913407
Dev Cell. 2017 Mar 13;40(5):429-438
pubmed: 28292422
Dev Cell. 2016 Nov 7;39(3):302-315
pubmed: 27746044
Dev Cell. 2015 Mar 9;32(5):640-51
pubmed: 25758862
Curr Biol. 2010 Feb 9;20(3):R89-92
pubmed: 20144774
Annu Rev Cell Dev Biol. 2011;27:377-407
pubmed: 21801015
Science. 2019 Jun 07;364(6444):948-951
pubmed: 31171690
Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):E9838-E9845
pubmed: 29087307
Cold Spring Harb Perspect Biol. 2014 Jun 26;7(11):
pubmed: 24968703
Am J Physiol. 1995 Oct;269(4 Pt 2):R848-55
pubmed: 7485602
Dev Cell. 2018 Oct 8;47(1):3-19
pubmed: 30300588
Science. 2012 Oct 12;338(6104):210-2
pubmed: 23066071
Elife. 2017 Apr 11;6:
pubmed: 28395731
Genes Dev. 2011 Sep 1;25(17):1871-80
pubmed: 21896659
J Biol Chem. 1982 Apr 25;257(8):4230-7
pubmed: 6279629
Mol Biol Cell. 2007 Oct;18(10):3788-99
pubmed: 17634290
Science. 2012 May 11;336(6082):721-4
pubmed: 22499809
Dev Growth Differ. 2008 Sep;50(7):615-21
pubmed: 18657169
Bioinformatics. 2011 Apr 15;27(8):1179-80
pubmed: 21349861
Dev Cell. 2002 Nov;3(5):745-56
pubmed: 12431380
Nat Rev Genet. 2007 May;8(5):368-81
pubmed: 17387317
Development. 2013 Apr;140(8):1621-38
pubmed: 23533171
Nature. 2014 Nov 6;515(7525):120-4
pubmed: 25337877
J Biol Chem. 1983 Aug 25;258(16):9681-9
pubmed: 6309781
Nat Protoc. 2014 Dec;9(12):2732-9
pubmed: 25356584
Curr Biol. 2012 Apr 24;22(8):668-75
pubmed: 22445299
PLoS One. 2019 May 9;14(5):e0216628
pubmed: 31071172
Science. 2017 Jun 30;356(6345):1379-1383
pubmed: 28663499
Mol Biol Cell. 2017 Oct 1;28(20):2701-2711
pubmed: 28768825
J Membr Biol. 2002 Jul 15;188(2):151-62
pubmed: 12172640
Curr Opin Genet Dev. 2011 Dec;21(6):704-10
pubmed: 21873045
Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16708-13
pubmed: 17940054
Nat Biotechnol. 2011 Jul 07;29(8):731-4
pubmed: 21738127
Nature. 2008 Sep 4;455(7209):72-7
pubmed: 18701888
Cell. 2011 Jun 10;145(6):875-89
pubmed: 21663792

Auteurs

Zhechun Zhang (Z)

Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA, 02138, USA. zhechunzhang@fas.harvard.edu.
School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, 02138, USA. zhechunzhang@fas.harvard.edu.

Steven Zwick (S)

School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, 02138, USA.

Ethan Loew (E)

Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA, 02138, USA.

Joshua S Grimley (JS)

Allen Institute for Brain Science, Seattle, WA, 98109, USA.
Universal Cells, Seattle, WA, 98121, USA.

Sharad Ramanathan (S)

Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA, 02138, USA. sharad@post.harvard.edu.
School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, 02138, USA. sharad@post.harvard.edu.
Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, 02138, USA. sharad@post.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH